Basic Information
| RNALocate ID: | RLID:11001398 |
| RNA Symbol: | hsa-miR-34a-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-34a-5p |
| RNA ID: | miRBase:MIMAT0000255 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23382797 |
| Tissue/Cell Line: | Brain tissue |
| Method: | Microarray |
| Description: | We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001607 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01001608 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001609 | Mitochondrion | Myotube | 27396686 |
| RLID:01001610 | Mitochondrion | Skeletal muscle cells | 27563705 |
| RLID:01001611 | Mitochondrion | Human umbilical vein endothelial cells | 30348904 |
| RLID:01001612 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001613 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001614 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11001395 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001396 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11001397 | Exosome | Breast milk | 22211110 |
| RLID:11001399 | Exosome | Plasma | 23663360 |
| RLID:11001400 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001401 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11001402 | Extracellular vesicle | Human mesenchymal stem cells | 25669974 |
| RLID:11001403 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001404 | Microvesicle | Serum | 24797360 |
| RLID-D:11000048 | Exosome | B lymphoblastoid cells | |
| RLID-D:11000317 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-34a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-42622 |
| MNDR | hsa-miR-34a-5p | Splenic marginal zone lymphoma | MNDR-E-MI-42623 |
| MNDR | hsa-miR-34a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-42624 |
| MNDR | hsa-miR-34a-5p | Proneural subtype glioblastoma | MNDR-E-MI-42625 |
| MNDR | hsa-miR-34a-5p | Glomerulosclerosis | MNDR-E-MI-42626 |
| MNDR | hsa-miR-34a-5p | Oral squamous cell carcinoma | MNDR-E-MI-42627 |
| MNDR | hsa-miR-34a-5p | Medulloblastoma | MNDR-E-MI-42628 |
| MNDR | hsa-miR-34a-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-42629 |
| MNDR | hsa-miR-34a-5p | Lymphoma | MNDR-E-MI-42630 |
| MNDR | hsa-miR-34a-5p | Lymphoma non-hodgkin | MNDR-E-MI-42631 |
| MNDR | hsa-miR-34a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-42632 |
| MNDR | hsa-miR-34a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-42633 |
| MNDR | hsa-miR-34a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-42634 |
| MNDR | hsa-miR-34a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-42635 |
| MNDR | hsa-miR-34a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-42636 |
| MNDR | hsa-miR-34a-5p | Triple negative breast cancer | MNDR-E-MI-42637 |
| MNDR | hsa-miR-34a-5p | Neuroblastoma with 1p36 deletion | MNDR-E-MI-42638 |
| MNDR | hsa-miR-34a-5p | Breast cancer luminal | MNDR-E-MI-42639 |
| MNDR | hsa-miR-34a-5p | Anencephaly | MNDR-E-MI-42640 |
| MNDR | hsa-miR-34a-5p | Niemann-pick disease type c | MNDR-E-MI-42641 |
| MNDR | hsa-miR-34a-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-42642 |
| MNDR | hsa-miR-34a-5p | Hearing loss central | MNDR-E-MI-42643 |
| MNDR | hsa-miR-34a-5p | Sensorineural hearing loss | MNDR-E-MI-42644 |
| MNDR | hsa-miR-34a-5p | Dermatomyositis | MNDR-E-MI-42645 |
| MNDR | hsa-miR-34a-5p | Prostate cancer | MNDR-E-MI-42646 |
| MNDR | hsa-miR-34a-5p | Chronic lymphocytic leukemia | MNDR-E-MI-42647 |
| MNDR | hsa-miR-34a-5p | Gastric cancer | MNDR-E-MI-42648 |
| MNDR | hsa-miR-34a-5p | Gastric lymphoma | MNDR-E-MI-42649 |
| MNDR | hsa-miR-34a-5p | Alzheimer disease | MNDR-E-MI-42650 |
| MNDR | hsa-miR-34a-5p | Intracranial aneurysm | MNDR-E-MI-42651 |
| MNDR | hsa-miR-34a-5p | Bladder cancer | MNDR-E-MI-42652 |
| MNDR | hsa-miR-34a-5p | Sarcoidosis | MNDR-E-MI-42653 |
| MNDR | hsa-miR-34a-5p | Dysautonomia familial | MNDR-E-MI-42654 |
| MNDR | hsa-miR-34a-5p | Myotonic dystrophy | MNDR-E-MI-42655 |
| MNDR | hsa-miR-34a-5p | Muscular dystrophy duchenne | MNDR-E-MI-42656 |
| MNDR | hsa-miR-34a-5p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-42657 |
| MNDR | hsa-miR-34a-5p | Prader-willi syndrome | MNDR-E-MI-42658 |
| MNDR | hsa-miR-34a-5p | Leukemia | MNDR-E-MI-42659 |
| MNDR | hsa-miR-34a-5p | Cardiovascular disease | MNDR-E-MI-42660 |
| MNDR | hsa-miR-34a-5p | Uterine fibroid | MNDR-E-MI-42661 |
| MNDR | hsa-miR-34a-5p | Lung cancer | MNDR-E-MI-42662 |
| MNDR | hsa-miR-34a-5p | Tuberous sclerosis | MNDR-E-MI-42663 |
| MNDR | hsa-miR-34a-5p | Parkinson disease | MNDR-E-MI-42664 |
| MNDR | hsa-miR-34a-5p | Niemann-pick disease | MNDR-E-MI-42665 |
| MNDR | hsa-miR-34a-5p | Primary pulmonary hypertension | MNDR-E-MI-42666 |
| MNDR | hsa-miR-34a-5p | Major depressive disorder | MNDR-E-MI-42667 |
| MNDR | hsa-miR-34a-5p | Basal-like breast cancer | MNDR-E-MI-42668 |
| MNDR | hsa-miR-34a-5p | Cancer | MNDR-E-MI-42669 |
| MNDR | hsa-miR-34a-5p | Squamous cell carcinoma | MNDR-E-MI-42670 |
| MNDR | hsa-miR-34a-5p | Pituitary neoplasms | MNDR-E-MI-42671 |
| MNDR | hsa-miR-34a-5p | Pancreatic cancer | MNDR-E-MI-42672 |
| MNDR | hsa-miR-34a-5p | Melanoma | MNDR-E-MI-42673 |
| MNDR | hsa-miR-34a-5p | Lesch-nyhan syndrome | MNDR-E-MI-42674 |
| MNDR | hsa-miR-34a-5p | Rectum adenocarcinoma | MNDR-E-MI-42675 |
| MNDR | hsa-miR-34a-5p | Nephroblastoma | MNDR-E-MI-42676 |
| MNDR | hsa-miR-34a-5p | Colon cancer | MNDR-E-MI-42677 |
| MNDR | hsa-miR-34a-5p | Colon adenocarcinoma | MNDR-E-MI-42678 |
| MNDR | hsa-miR-34a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-42679 |
| MNDR | hsa-miR-34a-5p | Ovarian cancer | MNDR-E-MI-42680 |
| MNDR | hsa-miR-34a-5p | Laryngeal squamous cell carcinoma | MNDR-E-MI-42681 |
| MNDR | hsa-miR-34a-5p | Glioblastoma | MNDR-E-MI-42682 |
| MNDR | hsa-miR-34a-5p | Astrocytoma | MNDR-E-MI-42683 |
| MNDR | hsa-miR-34a-5p | Glioma | MNDR-E-MI-42684 |
| MNDR | hsa-miR-34a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-42685 |
| MNDR | hsa-miR-34a-5p | Chordoma | MNDR-E-MI-42686 |
| MNDR | hsa-miR-34a-5p | Bipolar disorder | MNDR-E-MI-42687 |
| MNDR | hsa-miR-34a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-42688 |
| MNDR | hsa-miR-34a-5p | Osteosarcoma | MNDR-E-MI-42689 |
| MNDR | hsa-miR-34a-5p | Ewing sarcoma | MNDR-E-MI-42690 |
| MNDR | hsa-miR-34a-5p | Liposarcoma | MNDR-E-MI-42691 |
| MNDR | hsa-miR-34a-5p | Inclusion body myositis | MNDR-E-MI-42692 |
| MNDR | hsa-miR-34a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-42693 |
| MNDR | hsa-miR-34a-5p | Meningioma | MNDR-E-MI-42694 |
| MNDR | hsa-miR-34a-5p | Central nervous system cancer | MNDR-E-MI-42695 |
| MNDR | hsa-miR-34a-5p | Uterine cancer | MNDR-E-MI-42696 |
| MNDR | hsa-miR-34a-5p | Cervical adenocarcinoma | MNDR-E-MI-42697 |
| MNDR | hsa-miR-34a-5p | Gastric adenocarcinoma | MNDR-E-MI-42698 |
| MNDR | hsa-miR-34a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-42699 |
| MNDR | hsa-miR-34a-5p | Pulmonary fibrosis | MNDR-E-MI-42700 |
| MNDR | hsa-miR-34a-5p | Pituitary adenoma | MNDR-E-MI-42701 |
| MNDR | hsa-miR-34a-5p | Lung squamous cell carcinoma | MNDR-E-MI-42702 |
| MNDR | hsa-miR-34a-5p | Carcinoma lung non-small-cell | MNDR-E-MI-42703 |
| MNDR | hsa-miR-34a-5p | Lung adenocarcinoma | MNDR-E-MI-42704 |
| MNDR | hsa-miR-34a-5p | Thyroid carcinoma | MNDR-E-MI-42705 |
| MNDR | hsa-miR-34a-5p | Papillary thyroid carcinoma | MNDR-E-MI-42706 |
| MNDR | hsa-miR-34a-5p | Ovarian carcinoma | MNDR-E-MI-42707 |
| MNDR | hsa-miR-34a-5p | Invasive urothelial bladder carcinoma | MNDR-E-MI-42708 |
| MNDR | hsa-miR-34a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-42709 |
| MNDR | hsa-miR-34a-5p | Brain stem cancer | MNDR-E-MI-42710 |
| MNDR | hsa-miR-34a-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-42711 |
| MNDR | hsa-miR-34a-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-42712 |
| MNDR | hsa-miR-34a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-42713 |
| MNDR | hsa-miR-34a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-42714 |
| MNDR | hsa-miR-34a-5p | Cholangiocarcinoma | MNDR-E-MI-42715 |
| MNDR | hsa-miR-34a-5p | Oncocytoma | MNDR-E-MI-42716 |
| MNDR | hsa-miR-34a-5p | Lung small cell carcinoma | MNDR-E-MI-42717 |
| MNDR | hsa-miR-34a-5p | Schizophrenia | MNDR-E-MI-42718 |
| MNDR | hsa-miR-34a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-42719 |
| MNDR | hsa-miR-34a-5p | Myocardial infarction | MNDR-E-MI-42720 |
| MNDR | hsa-miR-34a-5p | Malignant peripheral nerve sheath tumor | MNDR-E-MI-42721 |
| MNDR | hsa-miR-34a-5p | Heart failure | MNDR-E-MI-42722 |
| MNDR | hsa-miR-34a-5p | Uveal melanoma | MNDR-E-MI-42723 |
| MNDR | hsa-miR-34a-5p | HBV+ hepatocellular carcinoma | MNDR-E-MI-42724 |
| MNDR | hsa-miR-34a-5p | Embryonal cancer | MNDR-E-MI-42725 |
| MNDR | hsa-miR-34a-5p | B-cell lymphoma | MNDR-E-MI-42726 |
| MNDR | hsa-miR-34a-5p | T-cell leukemia | MNDR-E-MI-42727 |
| MNDR | hsa-miR-34a-5p | Retinoblastoma | MNDR-E-MI-42728 |
| MNDR | hsa-miR-34a-5p | Neuroblastoma | MNDR-E-MI-42729 |
| MNDR | hsa-miR-34a-5p | Hodgkin disease | MNDR-E-MI-42730 |
| MNDR | hsa-miR-34a-5p | Burkitt lymphoma | MNDR-E-MI-42731 |
| MNDR | hsa-miR-34a-5p | Mouth neoplasms | MNDR-E-MI-42732 |
| MNDR | hsa-miR-34a-5p | Tonsil cancer | MNDR-E-MI-42733 |
| MNDR | hsa-miR-34a-5p | Skin cutaneous melanoma | MNDR-E-MI-42734 |
| MNDR | hsa-miR-34a-5p | Skin melanoma | MNDR-E-MI-42735 |
| MNDR | hsa-miR-34a-5p | Acute myelocytic leukemia | MNDR-E-MI-42736 |
| MNDR | hsa-miR-34a-5p | Colorectal cancer | MNDR-E-MI-42737 |
| MNDR | hsa-miR-34a-5p | Nasopharynx carcinoma | MNDR-E-MI-42738 |
| MNDR | hsa-miR-34a-5p | Acute lymphocytic leukemia | MNDR-E-MI-42739 |
| MNDR | hsa-miR-34a-5p | Esophageal squamous cancer | MNDR-E-MI-42740 |
| MNDR | hsa-miR-34a-5p | Ependymoma | MNDR-E-MI-42741 |
| MNDR | hsa-miR-34a-5p | Nasopharyngeal cancer | MNDR-E-MI-42742 |
| MNDR | hsa-miR-34a-5p | Prostatic neoplasms | MNDR-E-MI-42743 |
| MNDR | hsa-miR-34a-5p | Polymyositis | MNDR-E-MI-42744 |
| MNDR | hsa-miR-34a-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-42745 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABLIM1 | Homo sapiens | RR00027318 |
TOP